WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2018 will be released before market open on Thursday, August 2, 2018. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, August 2, 2018. The call can be accessed through a […]
Other News
Corindus Announces Significant Progress in the Development of Remote Vascular Robotic Technology with the CorPath GRX® System
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that Ryan Madder, M.D., an interventional cardiologist at Spectrum Health, has successfully completed a remote percutaneous coronary intervention (PCI) in a porcine model using the CorPath GRX System from a location greater than […]
ZOLL Heroes for Life Program Recognizes Everyday People Making a Difference with ZOLL AEDs
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that it is launching a Heroes for Life™ program to honor “unexpected heroes” who have helped save the life of a sudden cardiac arrest (SCA) victim with a ZOLL AED and […]
LeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018
BURLINGTON, Mass., July 18, 2018 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2018 financial results on Thursday, July 26, 2018, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and […]
iRhythm Technologies to Report Second Quarter Financial Results on August 1, 2018
SAN FRANCISCO, July 18, 2018 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the second quarter 2018 after the close of trading on Wednesday, August 1, 2018. The company’s management […]
Medtronic Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure Therapy
DUBLIN – July 19, 2018 – Medtronic plc (NYSE: MDT) today announced first enrollments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool for optimizing cardiac resynchronization therapy (CRT) for patients with heart failure. The first patient enrolled in the ECG Belt for […]
Boehringer Ingelheim and Lilly announce Tradjenta’s CARMELINA® cardiovascular outcome trial meets primary endpoint
RIDGEFIELD, Conn. and INDIANAPOLIS, July 19, 2018 /PRNewswire/ — CARMELINA® (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its primary endpoint, defined as time to first occurrence of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke (3-point MACE), with Tradjenta® demonstrating similar cardiovascular safety compared with […]
Fujifilm Presents Cardiovascular Imaging Solutions at the World Society for Pediatric and Congenital Heart Surgery’s 6th Scientific Meeting
STAMFORD, Conn., July 19, 2018 /PRNewswire/ — (Booth 106) — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Informatics solutions, will demonstrate Synapse® Cardiovascular, its comprehensive enterprise solution for cardiology, at the World Society for Pediatric and Congenital Heart Surgery’s (WSPCHS) 6thscientific meeting. This meeting is the premier gathering of the largest professional […]
B. Braun to Acquire Bloodlines Business of NxStage Medical, Inc.
BETHLEHEM, Pa., July 19, 2018 (GLOBE NEWSWIRE) — B. Braun Medical Inc. (B. Braun), a market leader in renal therapies, infusion therapy, and pain management, has signed an agreement to acquire the bloodlines business operated under the Medisystems® name by NxStage Medical, Inc. (Nasdaq:NXTM), a medical technology company based in Lawrence, […]
Bardy Diagnostics™ Announces Additional Growth Capital Funding
SEATTLE, July 16, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today it has raised additional growth capital from its existing equity […]